✦ LIBER ✦

Phase III trial of oral ibandronate and intravenous zoledronic acid in breast cancer patients with bone metastases: comparative bone turnover marker and safety data

✍ Scribed by J.-J. Body; Lichinitser; S. Tjulandin; B. Bergström

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Oral ibandronate and intravenous zoledro

✍ J.J. Body; M. Lichinitser; R.E. Coleman; B. Bergström 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 51 KB

405 POSTER Phase III trial of oral iband

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 138 KB

408 POSTER Safety comparison of oral iba

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 125 KB

Renal safety of ibandronate in patients

✍ R Bell; I.J Diel; J Body; B Bergström 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 173 KB

Effects of intravenous zoledronic acid a

✍ Filippo Francini; Alessandra Pascucci; Gianluca Bargagli; Edoardo Francini; Raff 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 253 KB

Cost-Effectiveness of Denosumab Compared

✍ Jipan Xie; Melissa Diener; Rachael Sorg; Eric Q. Wu; Madhav Namjoshi 📂 Article 📅 2012 🏛 CIG Media Group, LP. 🌐 English ⚖ 544 KB